March 1 (Reuters) - Xenon Pharmaceuticals Inc XENE.O :
* XENON PHARMACEUTICALS REPORTS 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* XENON PHARMACEUTICALS INC - XEN1101 PHASE 2B "X-TOLE" CLINICAL TRIAL IN ADULT FOCAL EPILEPSY ON TRACK FOR TOPLINE DATA IN Q3 OF 2021
* XENON PHARMACEUTICALS INC - ANTICIPATES HAVING SUFFICIENT CASH TO FUND OPERATIONS INTO 2023